Clinical Trial Update: A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis

View source ↗

Summary

A clinical trial evaluating Lebrikizumab's effect on health-related quality of life and skin disease control in adults with moderate-to-severe atopic dermatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Atopic Dermatitis, Eczema | Status: RECRUITING